Immunotherapy in patients with cervical cancer
Immunotherapy, also known as therapy with immune checkpoint inhibitors, has shown good results in the treatment of both solid tumors and hematological malignancies. Patients with diseases that were considered incurable earlier now have an opportunity for long-term disease stabilization and high freq...
Main Author: | A. G. Kedrova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2020-11-01
|
Series: | Опухоли женской репродуктивной системы |
Subjects: | |
Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/738 |
Similar Items
-
Countermeasures and Mechanisms of Drug Resistance in Immunotherapy for Cervical Cancer
by: YANG Junyuan, et al.
Published: (2022-09-01) -
Case Report: Immune Checkpoint Inhibitors as a Single Agent in the Treatment of Metastatic Cervical Cancer
by: Manasa Anipindi, et al.
Published: (2022-04-01) -
Current and Future Role of Neoadjuvant Chemoimmunotherapy for Early Triple-Negative Breast Cancer: Which Way to Go Forward
by: Alessandro Rizzo, et al.
Published: (2022-04-01) -
How Immunotherapy Modified the Therapeutic Scenario of Endometrial Cancer: A Systematic Review
by: Brigida Anna Maiorano, et al.
Published: (2022-04-01) -
High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status
by: Alessio Cortellini, et al.
Published: (2022-01-01)